Ticagrelor with or without aspirin following percutaneous coronary intervention in high-risk patients with concomitant peripheral artery disease: A subgroup analysis of the TWILIGHT randomized clinical trial

Mitchell Krucoff, Alessandro Spirito, Usman Baber, Samantha Sartori, Dominick J. Angiolillo, Carlo Briguori, David J. Cohen, Timothy Collier, George Dangas, Dariusz Dudek, Javier Escaned, C. Michael Gibson, Ya Ling Han, Kurt Huber, Adnan Kastrati, Upendra Kaul, Ran Kornowski, Vijay Kunadian, Birgit Vogel, Shamir R. MehtaDavid Moliterno, Gennaro Sardella, Richard A. Shlofmitz, Samin Sharma, Philippe Gabriel Steg, Stuart Pocock, Roxana Mehran

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Ticagrelor with or without aspirin following percutaneous coronary intervention in high-risk patients with concomitant peripheral artery disease: A subgroup analysis of the TWILIGHT randomized clinical trial'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science